Invasive fungal infection: Difference between revisions
From IDWiki
m (Aidan moved page Invasive fungal infections to Invasive fungal infection without leaving a redirect) |
(→) |
||
| Line 1: | Line 1: | ||
== Organisms == |
== Organisms == |
||
| − | * |
+ | * [[Aspergillus species]] |
* [[Mucormycosis]] |
* [[Mucormycosis]] |
||
| − | * |
+ | * [[Cryptococcus]]? |
| − | * |
+ | * [[Penicillium]] |
* Others... |
* Others... |
||
Revision as of 16:38, 22 September 2019
Organisms
- Aspergillus species
- Mucormycosis
- Cryptococcus?
- Penicillium
- Others...
Epidemiology
- Among patients on posaconazole for a hematologic malignancy or bone marrow transplant, there is an approximately 2% rate of breakthrough infection
References
- ^ Oliver A. Cornely, Johan Maertens, Drew J. Winston, John Perfect, Andrew J. Ullmann, Thomas J. Walsh, David Helfgott, Jerzy Holowiecki, Dick Stockelberg, Yeow-Tee Goh, Mario Petrini, Cathy Hardalo, Ramachandran Suresh, David Angulo-Gonzalez. Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia. New England Journal of Medicine. 2007;356(4):348-359. doi:10.1056/nejmoa061094.
